CUV may well list on the Nasdaq one day but the conditions would...

CUV may well list on the Nasdaq one day but the conditions would have to be right. PW indicated a while back that others have not been that successful despite listing there. Interesting to note TLX today withdrew from their attempt as the price they could get seems too low relative to current trading price. Don't see it as a priority right now until investor sentiment improves for CUV. Between 2019 and 2022 long term holders could have walked away at bw $35-$40 and been relatively rich. Some did. Anyone worked for an ASX listed company and been obsessed with the daily SP? I imagine CUV are getting on with the slow progress and who knows what the broker strategy is with the BB? Getting the first melanocortin approved and getting two capital raises off at a premium is reasonable results when you look at some alternatives -MSB, PAR, IMU etc. You could pick the eyes out of the biotechs and be pretty happy if you are on TLX, NEU PME (albeit tech/bio). There's plenty of train wrecks around these. Where does CUV fit? Time will tell. Each to their own. GLTA